Chondroitin Polymerizing Factor (CHPF) Promotes the Progression of Colorectal Cancer Through ASB2-mediated Ubiquitylation of SMAD9

Overview

Journal Histol Histopathol

Specialties Anatomy & Histology
Pathology

Date 2024 Apr 9

PMID 38591191

Authors

Jiang Zhao

Xiaolong Tang

Huijun Zhu

Affiliations

Soon will be listed here.

Abstract

Chondroitin polymerizing factor (CHPF) has been reported to play a pivotal role in the progression of multiple cancers, however, the relationship between CHPF and colorectal cancer (CRC) progression has not been fully understood. The current study revealed that CHPF expression was upregulated in patients with CRC and correlated with an unfavorable prognosis. Also, CHPF knockdown effectively suppressed the viability and mobility of CRC cells and the growth of xenograft tumors. Additionally, SMAD9 was identified as a downstream target of CHPF. SMAD9 knockdown successfully abrogated the promotion of CHPF overexpression in CRC progression, indicating that CHPF regulated the development of CRC through SMAD9. Mechanistically, SMAD9 is ubiquitinated by ASB2, and the regulatory effect of CHPF on SMAD9 activity was exerted via its mediation of ASB2. Collectively, CHPF functioned as a promising prognostic biomarker and tumor-promoter of CRC by regulating the ASB2-mediated ubiquitination of SMAD9.

References

Abuzar S, Park E, Seo Y, Lee J, Baik S, Hwang S . Preparation and Evaluation of Intraperitoneal Long-Acting Oxaliplatin-Loaded Multi-Vesicular Liposomal Depot for Colorectal Cancer Treatment. Pharmaceutics. 2020; 12(8). PMC: 7466130. DOI: 10.3390/pharmaceutics12080736. View

Batlle E, Massague J . Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity. 2019; 50(4):924-940. PMC: 7507121. DOI: 10.1016/j.immuni.2019.03.024. View

Cao C, Liu Y, Wang Q, Zhao J, Shi M, Zheng J . Expression of CHPF modulates cell proliferation and invasion in lung cancer. Braz J Med Biol Res. 2020; 53(5):e9021. PMC: 7205412. DOI: 10.1590/1414-431x20209021. View

Chen Z, Zhou Y, Song J, Zhang Z . hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties. Biochim Biophys Acta. 2013; 1834(8):1461-7. DOI: 10.1016/j.bbapap.2013.04.006. View

Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B . METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020; 19(1):106. PMC: 7298962. DOI: 10.1186/s12943-020-01220-7. View

Cheng M, Zhao Y, Cui Y, Zhong C, Zha Y, Li S . Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis. Ann Rheum Dis. 2022; 81(12):1669-1677. PMC: 9664099. DOI: 10.1136/ard-2022-222871. View

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

Ding R, Chen Z, He M, Cen H, Liu Z, Su Y . Application Value of Combined Detection of NLR, PNI, D-Dimer, CD3 T Lymphocytes, and CEA in Colorectal Cancer Screening. Dis Markers. 2022; 2022:7913025. PMC: 8958083. DOI: 10.1155/2022/7913025. View

Esmaeili-Fard S, Gholizadeh M, Hafezian S, Abdollahi-Arpanahi R . Genes and Pathways Affecting Sheep Productivity Traits: Genetic Parameters, Genome-Wide Association Mapping, and Pathway Enrichment Analysis. Front Genet. 2021; 12:710613. PMC: 8355708. DOI: 10.3389/fgene.2021.710613. View

10.

Gao L, Tian Q, Wu T, Shi S, Yin X, Liu L . Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis. J Transl Med. 2021; 19(1):37. PMC: 7816389. DOI: 10.1186/s12967-020-02654-9. View

11.

Heuze M, Guibal F, Banks C, Conaway J, Conaway R, Cayre Y . ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex. J Biol Chem. 2004; 280(7):5468-74. DOI: 10.1074/jbc.M413040200. View

12.

Hou X, Baloch Z, Zheng Z, Zhang W, Feng Y, Li D . Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer. Cancer Manag Res. 2019; 11:3275-3283. PMC: 6499445. DOI: 10.2147/CMAR.S192036. View

13.

Jiang H, Dong L, Gong F, Gu Y, Zhang H, Fan D . Inflammatory genes are novel prognostic biomarkers for colorectal cancer. Int J Mol Med. 2018; 42(1):368-380. PMC: 5979867. DOI: 10.3892/ijmm.2018.3631. View

14.

Kim M, Min Y, Jang J, Park H, Lee S, Lee C . Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer. J Immunother Cancer. 2021; 9(7). PMC: 8276303. DOI: 10.1136/jitc-2021-002503. View

15.

Kitagawa H, Izumikawa T, Uyama T, Sugahara K . Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. J Biol Chem. 2003; 278(26):23666-71. DOI: 10.1074/jbc.M302493200. View

16.

Li T, Guo H, Song Y, Zhao X, Shi Y, Lu Y . Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer. Mol Cancer. 2014; 13:263. PMC: 4320448. DOI: 10.1186/1476-4598-13-263. View

17.

Li X, Wang Z, Ye C, Zhao B, Li Z, Yang Y . RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018; 37(1):325. PMC: 6307166. DOI: 10.1186/s13046-018-1006-x. View

18.

Li W, Liu B, Dong S, He S, Liu Y, Wei S . Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. Front Oncol. 2022; 12:856712. PMC: 8965246. DOI: 10.3389/fonc.2022.856712. View

19.

Liao W, Yen H, Chen C, Chu Y, Song Y, Tseng T . CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment. Am J Cancer Res. 2021; 11(3):812-826. PMC: 7994168. View

20.

Lin X, Han T, Xia Q, Cui J, Zhuo M, Liang Y . CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Cell Death Dis. 2021; 12(10):876. PMC: 8464597. DOI: 10.1038/s41419-021-04148-y. View